An automated platform for multiparameter data collection on live pathogens of higher or unknown biosafety risk (CAPS-IT) KU Leuven
Almost every year, known or newly-discovered pathogens with a significant impact on human health grip the worlds' attention. Still, for many, if not most of them, no efficient drugs are currently available, leaving only supportive care to ease the symptoms of the disease. Novel drugs and strategies for the treatment or prevention of infectious diseases can only be discovered and developed by studying and unraveling in detail how viruses replicate, and how bacteria, fungi and parasites multiply.
Research on infectious diseases, in particular those of higher or unknown biosafety risk ...